Sentinel node biopsy for axillary management after neoadjuvant therapy for breast cancer: a single-center retrospective analysis with long follow-up

Sentinel node biopsy for axillary management after neoadjuvant therapy for breast cancer: a... Surg Today (2018) 48:87–94 https://doi.org/10.1007/s00595-017-1558-y ORIGINAL ARTICLE Sentinel node biopsy for axillary management after neoadjuvant therapy for breast cancer: a single‑center retrospective analysis with long follow‑up 1 1 1 1 Yoshinari Ogawa · Katsumi Ikeda · Chika Watanabe · Yuri Kamei · 2 2 3 3 Shinya Tokunaga · Yuko Tsuboguchi · Takeshi Inoue · Hiroko Fukushima · Makoto Ichiki Received: 25 March 2017 / Accepted: 28 May 2017 / Published online: 24 June 2017 © Springer Japan KK 2017 Abstract follow-up time of 63 months. Of the 33 patients who did Purpose Sentinel node biopsy (SNB) after neoadjuvant not undergo ALND, 10 suffered recurrence (33%). One therapy (NAT) for breast cancer remains controversial. patient (3%) had recurrence in an axillary lymph node and We conducted a retrospective study of patients who under- four had recurrence in a supraclavicular lymph node. went SNB after NAT to evaluate the effectiveness of this Conclusion Axillary SNB after NAT did not affect the axil- procedure. lary failure rate or the prognosis. SNB may be a reliable Methods A consecutive 105 women with locally advanced procedure, even after NAT. breast cancer (cT1–4, cN0–3, M0) were treated with NAT between 2006 and 2015. The http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Surgery Today Springer Journals

Sentinel node biopsy for axillary management after neoadjuvant therapy for breast cancer: a single-center retrospective analysis with long follow-up

Loading next page...
 
/lp/springer_journal/sentinel-node-biopsy-for-axillary-management-after-neoadjuvant-therapy-qmcuvzspaj
Publisher
Springer Journals
Copyright
Copyright © 2017 by Springer Japan KK
Subject
Medicine & Public Health; Surgery; Surgical Oncology
ISSN
0941-1291
eISSN
1436-2813
D.O.I.
10.1007/s00595-017-1558-y
Publisher site
See Article on Publisher Site

Abstract

Surg Today (2018) 48:87–94 https://doi.org/10.1007/s00595-017-1558-y ORIGINAL ARTICLE Sentinel node biopsy for axillary management after neoadjuvant therapy for breast cancer: a single‑center retrospective analysis with long follow‑up 1 1 1 1 Yoshinari Ogawa · Katsumi Ikeda · Chika Watanabe · Yuri Kamei · 2 2 3 3 Shinya Tokunaga · Yuko Tsuboguchi · Takeshi Inoue · Hiroko Fukushima · Makoto Ichiki Received: 25 March 2017 / Accepted: 28 May 2017 / Published online: 24 June 2017 © Springer Japan KK 2017 Abstract follow-up time of 63 months. Of the 33 patients who did Purpose Sentinel node biopsy (SNB) after neoadjuvant not undergo ALND, 10 suffered recurrence (33%). One therapy (NAT) for breast cancer remains controversial. patient (3%) had recurrence in an axillary lymph node and We conducted a retrospective study of patients who under- four had recurrence in a supraclavicular lymph node. went SNB after NAT to evaluate the effectiveness of this Conclusion Axillary SNB after NAT did not affect the axil- procedure. lary failure rate or the prognosis. SNB may be a reliable Methods A consecutive 105 women with locally advanced procedure, even after NAT. breast cancer (cT1–4, cN0–3, M0) were treated with NAT between 2006 and 2015. The

Journal

Surgery TodaySpringer Journals

Published: Jun 24, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off